Professional Documents
Culture Documents
START HERE PFIZER SETTLES $2.3 Billion ILLEGAL DRUG PROMOTION AND
FRAUD CASE IN HISTORY OF AMERICA.
2018
August 16
2020
July 28
November 9
November 18
What the Public Sees Pfizer CEO Says Companies Should Make Profit on Covid-19 Great Day for Humanity - Pfizer Says Covid-19 Vaccine Over
Pfizer Vaccine Trial Ends with 95% Success Rate
Vaccines
90% Effective
November 17
2021
October 20
November 2
November 9
November 15
More people died in the key clinical trial for Pfizer's Covid
July 28
Pfizer has power to 'silence' governments and 'maximize COVID-19: Researcher blows the whistle on data integrity Pfizer CEO says people who spread misinformation on COVID
COVID-19 Vaccines to Prevent SARS CoV-2 Infection
Pfizer's CEO says Covid vaccine effectiveness drops to 84% profits', consumer group alleges. issues in Pfizer's vaccine trial vaccines are 'criminals'.
Continuing to Follow the Science: An Open Letter from Pfizer
after six months
Chairman and CEO Dr. Albert Bourla
2020
November 18
July 28
Vaccines
August 16
October 11
October 20
November 2
September 27
July 21
CNBC Exclusive: CNBC Transcript: Pfizer Chairman and CEO Pfizer and BioNTech Announce Submission of Initial Data to Scientists Sue the FDA for Data it Relied Upon to License Pfizer has power to 'silence' governments and 'maximize COVID-19: Researcher blows the whistle on data integrity
Pfizer starts study of mRNA based next generation flu vaccine
Albert Bourla Speaks with CNBC's The Exchange" Today
US FDA to Support Booster Dose of COVID 19 Vaccine. Pfizer's Covid-19 Vaccine. profits', consumer group alleges. issues in Pfizer's vaccine trial
Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing
2018
August 16
2021
November 15
November 18
November 18
September 27
Lab Alert: Changes to CDC RT PCR for SARS COV 2 Testing
Pfizer's Novel COVID 19 Oral Antiviral
Treatment Candidate
FDA wants to shield public from Pfizer Covid Continuing to Follow the Science: An Open Letter from Pfizer Pfizer to provider US government with 10-million treatment
Pfizer's Novel COVID 19 Oral Antiviral Treatment Candidate
July 28
Data for 55-years Chairman and CEO Dr. Albert Bourla courses with investigational oral antiviral candidate
THE SECRET MOLECULE
CNBC Exclusive: CNBC Transcript: Pfizer Chairman and CEO
Albert Bourla Speaks with CNBC's The Exchange" Today
END HERE
OPEN
CORE FILES